4//SEC Filing
Spring Bank Pharmaceuticals, Inc. 4
Accession 0001209191-16-137269
CIK 0001566373operating
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 5:11 PM ET
Size
6.1 KB
Accession
0001209191-16-137269
Insider Transaction Report
Form 4
Afdhal Nezam H.
Chief Medical Officer
Transactions
- Purchase
Common Stock
2016-08-15$11.43/sh+1,800$20,574→ 35,650 total - Purchase
Common Stock
2016-08-16$11.49/sh+100$1,149→ 35,750 total
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001566373
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 5:11 PM ET
- Size
- 6.1 KB